Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.

Jacky T YeungVesal YaghoobiDanielle MiyagishimaMatthew D VeselyTianxiang ZhangTi BadriAla NassarXue HanMiguel F SanmamedMark YoungbloodMatthieu PeyreMichel KalamaridesDavid L RimmMurat GunelLieping Chen

Published in: Neuro-oncology (2021)

Our findings suggest that anti-CSF1/CSF1R antibody treatment may be an effective normalization cancer immunotherapy for malignant meningiomas.

Keyphrases

cerebrospinal fluid
combination therapy
risk assessment
replacement therapy
smoking cessation